Nisa Investment Advisors
LXEO icon

Nisa Investment Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Nisa Investment Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
2,765
-2,100
-43% -$11.4K ﹤0.01% 2402
2026
Q1 		$27.9K Buy
4,865
+2,100
+76% +$14.9K ﹤0.01% 1892
2025
Q4 		$27.5K Hold
2,765
– – ﹤0.01% 1821
2025
Q3 		$18.4K Hold
2,765
– – ﹤0.01% 2044
2025
Q2 		$11.1K Buy
2,765
+2,426
+716% +$7.98K ﹤0.01% 2213
2025
Q1 		$1.18K Sell
339
-57
-14% -$253 ﹤0.01% 2595
2024
Q4 		$2.61K Buy
+396
New +$3.12K ﹤0.01% 2410
2024
Q3 		– Sell
-32
Closed -$513 – 3011
2024
Q2 		$513 Buy
+32
New +$465 ﹤0.01% 2678

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Nisa Investment Advisors's LXEO Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Lexeo Therapeutics (LXEO) stake by 43% in Q2 2026, selling an estimated $11.4K and leaving 2,765 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Nisa Investment Advisors first reported a position in LXEO in Q2 2024 and has held it in 8 quarters since. The position peaked at $27.9K in Q1 2026. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Nisa Investment Advisors held 2,765 shares of Lexeo Therapeutics worth $12.9K as of Q2 2026.
  • Nisa Investment Advisors sold 2,100 Lexeo Therapeutics shares in Q2 2026, an estimated $11.4K.
  • Lexeo Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2402 holding.
  • Nisa Investment Advisors first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Lexeo Therapeutics position peaked at $27.9K in Q1 2026.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.